COSA 2015*
Chairs: David Goldstein & Heather Cunliffe
How empowered do carriers of hereditary cancer gene mutations participating in an annual review program feel about managing their cancer risk? (#72)
11:00 AM
The Genomic Cancer Clinical Trial Initiative – collaboration toward achieving common goals (#73)
11:15 AM
Neuroendocrine tumor (NET) Oceania patient experience: results from the first global NET patient survey - A collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis (#74)
11:30 AM
Rare and uncommon cancers: impact on quality of life, psychological morbidity, and use of CAMs (#75)
11:45 AM
Management of Bone Cancers in Australian Adolescents and Young Adults (AYAs) (#76)
12:00 PM
Analysis of screening program for Von Hippel-Lindau and SDH mutation carriers. (#77)
12:15 PM